Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study.

Saved in:
Bibliographic Details
Title: Safety of a New Subcutaneous Testosterone Enanthate Auto-Injector: Results of a 26-Week Study.
Authors: Gittelman M; Uromedix, Aventura, FL, USA., Jaffe JS; Antares Pharma, Inc., Ewing, NJ, USA. Electronic address: jjaffe@antarespharma.com., Kaminetsky JC; Manhattan Medical Research, New York, NY, USA.
Source: The journal of sexual medicine [J Sex Med] 2019 Nov; Vol. 16 (11), pp. 1741-1748. Date of Electronic Publication: 2019 Sep 21.
Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: Netherlands NLM ID: 101230693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-6109 (Electronic) Linking ISSN: 17436095 NLM ISO Abbreviation: J Sex Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1743-6109
DOI:10.1016/j.jsxm.2019.08.013